Parents
Sign in to add mentor| David Weinstein | grad student | 2006 | Columbia | |
| (Trade, technology, and wages.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Avivi I, Canals C, Vernant JP, et al. (2014) Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma. Bone Marrow Transplantation. 49: 671-8 |
| Rodrigues CA, Rocha V, Dreger P, et al. (2014) Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood. Haematologica. 99: 370-7 |
| Robinson SP, Canals C, Luang JJ, et al. (2013) The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplantation. 48: 1409-14 |
| Sureda A, Canals C, Arranz R, et al. (2012) Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 97: 310-7 |
| Jantunen E, Canals C, Attal M, et al. (2012) Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT). Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 166-71 |
| van Kampen RJ, Canals C, Schouten HC, et al. (2011) Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1342-8 |
| Kyriakou C, Canals C, Cornelissen JJ, et al. (2010) Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4926-34 |
| Duarte RF, Canals C, Onida F, et al. (2010) Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4492-9 |
| Kyriakou C, Canals C, Sibon D, et al. (2010) High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2227-32 |
| Avivi I, Montoto S, Canals C, et al. (2009) Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. British Journal of Haematology. 147: 719-28 |